Michelle joined qPharmetra in 2021 with 14 years of experience as a Pharmacometrics Consultant. She has quantitative drug development experience in oncology, hematology, cardiovascular disease, vaccines, and infectious diseases. Michelle’s enthusiasm for consulting is fueled by the opportunity to collaborate with clients across all phases of drug development, from population PK and PK/PD analyses in support of regulatory submissions to model-based meta-analyses informing go/no-go decisions.
This person is not in any offices